Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient oversight of mtier with Type 2 insulin-dependent insulin-dependent diabetes mellitus Undergoing General Surgery (RABBIT-2 Surgery) found that care with a basal-bolus regimen that appear Lantus (insulin glargine injection) once-daily and Apidra (insulin glulisine injection) before meals improved glycemic control and reduced mash unit complications, compared to "sliding scale" insulin in general surgery vocation with type 2 diabetes.

More: - The rest...